멀티오믹스 시장 : 제품 유형, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Multiomics Market was valued at USD 83.55 billion in 2023, expected to reach USD 96.86 billion in 2024, and is projected to grow at a CAGR of 16.26%, to USD 239.92 billion by 2030.

Multiomics is a comprehensive approach within the field of biological research that integrates multiple "omics" technologies, such as genomics, transcriptomics, proteomics, and metabolomics, to provide an all-encompassing view of the molecular constituents of cells, tissues, and organisms. The necessity of multiomics arises from the complex nature of biological systems and the need to understand how different molecular components interact and contribute to health and disease states. Its applications span personalized medicine, biomarker discovery, drug development, and agriculture.

The end-use scope includes pharmaceuticals, biotechnology companies, research institutions, hospitals, and clinics. Multiomics has proven essential for advancing precision medicine, allowing for more targeted therapies and personalized treatment plans, while playing a pivotal role in drug discovery and therapeutic development. Moreover, it helps in agricultural biotechnology by enhancing crop breeding and resilience, contributing significantly to food security.

Market growth factors include advancements in omics technologies, increased investment in research and development, the prevalence of chronic diseases, and a growing emphasis on personalized healthcare. Key opportunities can be found in the rising demand for precision medicine, emerging markets, and the integration of artificial intelligence with multiomics data for enhanced analytics. Expanding partnerships between academic institutions and biotechnology firms could also offer a significant boost.

However, market growth faces challenges such as high costs associated with omics technologies, complex data interpretation, and the need for high-level bioinformatics expertise. Privacy concerns and regulatory constraints further complicate multiomics research and application.

Innovation and research could focus on developing more cost-effective and scalable omics technologies, improving data integration methods, and enhancing bioinformatics tools for better data analysis. Optimizing these areas would address existing challenges and drive market expansion. Despite the competitive nature of the market, there remains potential for significant growth by focusing on emerging fields such as systems biology and by fostering collaborations across sectors to harness collective expertise and leverage emerging technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiomics Market

The Multiomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
  • High potential owing to a growing preference towards personalized medicines
  • Rising research & development activities conducted by biotechnology companies
• Market Restraints
  • High cost and limited skilled professionals associated with multiomics
• Market Opportunities
  • Growing integration of advanced technologies into multiomics
  • Increasing investments in agriculture research and environmental science with sustainability targets
• Market Challenges
  • Limited standard protocols for data acquisition, storage, and sharing across omics studies

Porter's Five Forces: A Strategic Tool for Navigating the Multiomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiomics Market

A detailed market share analysis in the Multiomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiomics Market

A strategic analysis of the Multiomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instrument, and Software.
• Based on Type, market is studied across Epigenomics, Genomics, Metabolomics, Microbiomics, Proteomics, and Transcriptomics.
• Based on Application, market is studied across Agriculture & Plant Science, Diagnostics, Drug Discovery, and Precision Medicine.
• Based on End-User, market is studied across Academic & Research Institutes, Biotechnology Companies, Hospitals & Clinics, and Pharmaceutical & Biopharmaceutical Companies. The Biotechnology Companies is further studied across Agriculture, Environmental Science, Forensics, and Plant & Animal Breeding.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
    • 5.1.1.2. High potential owing to a growing preference towards personalized medicines
    • 5.1.1.3. Rising research & development activities conducted by biotechnology companies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and limited skilled professionals associated with multiomics
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing integration of advanced technologies into multiomics
    • 5.1.3.2. Increasing investments in agriculture research and environmental science with sustainability targets
  • 5.1.4. Challenges
    • 5.1.4.1. Limited standard protocols for data acquisition, storage, and sharing across omics studies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Multiomics Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instrument
• 6.4. Software

7. Multiomics Market, by Type

• 7.1. Introduction
• 7.2. Epigenomics
• 7.3. Genomics
• 7.4. Metabolomics
• 7.5. Microbiomics
• 7.6. Proteomics
• 7.7. Transcriptomics

8. Multiomics Market, by Application

• 8.1. Introduction
• 8.2. Agriculture & Plant Science
• 8.3. Diagnostics
• 8.4. Drug Discovery
• 8.5. Precision Medicine

9. Multiomics Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Biotechnology Companies
  • 9.3.1. Agriculture
  • 9.3.2. Environmental Science
  • 9.3.3. Forensics
  • 9.3.4. Plant & Animal Breeding
• 9.4. Hospitals & Clinics
• 9.5. Pharmaceutical & Biopharmaceutical Companies

10. Americas Multiomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Multiomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Multiomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. MultiOmic Health Closes USD 6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
  • 13.3.2. Biomodal Launches New Multiomics Sequencing Technology
  • 13.3.3. Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics
  • 13.3.4. BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. AstraZeneca PLC
• 3. Becton, Dickinson and Company
• 4. Berkeley Lights, Inc.
• 5. BGI Genomics Co. Ltd
• 6. Bio-Rad Laboratories, Inc.
• 7. Bio-Techne Corporation
• 8. BioLegend, Inc. by PerkinElmer, Inc.
• 9. Celsee
• 10. Charles River Laboratories International, Inc.
• 11. Danaher Corporation
• 12. Dolomite Bio by Unchained Labs
• 13. EpiCypher, Inc.
• 14. Google LLC by Alphabet Inc.
• 15. Illumina, Inc.
• 16. Miltenyi Biotec
• 17. Mission Bio, Inc.
• 18. Multiomic Health Limited
• 19. NanoCellect Biomedical
• 20. NanoString Technologies, Inc.
• 21. Novo Nordisk A/S
• 22. Olink Proteomics AB
• 23. QIAGEN N.V.
• 24. Shimadzu Corporation
• 25. Singleron Biotechnologies GmbH
• 26. Standard BioTools Inc.
• 27. TAKARA BIO INC.
• 28. Tempus Labs, Inc.
• 29. Thermo Fischer Scientific Inc.